Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

6 PROCARE – phase 2 KCE reports 81Figure 1. Conceptual flowchart for the set-up of a quality indicator system in oncology.
KCE Reports 81 PROCARE – phase 2 72 DEVELOPMENT OF A QUALITY INDICATORSET2.1 METHODOLOGY2.1.1 Literature searchDuring the pre-assessment of the literature, an interesting good-quality systematicreview of colorectal cancer quality indicators was identified [3] . Although only studieswith US data were included in this review, it was decided to take this study as a startingpoint, and to perform an update of the review, expanding the inclusion criteria tostudies with non-US data.The Medline database was searched using the following combination of MeSH terms:("Colorectal Neoplasms" [MeSH] or "Rectal Neoplasms" [MeSH] or "ColonicNeoplasms" [MeSH]) AND ("Quality of Health Care" [MeSH] OR "Patient CareManagement" [MeSH] OR "Organization and Administration" [MeSH] OR "Health CareQuality, Access, and Evaluation" [MeSH] OR "Quality Indicators, Health Care" [MeSH]).The Cochrane Library was also searched using the free text words rectal and indicator.The search was done in January 2007 by 2 independent researchers (LVE and JV), andlimited to papers published from 2005 on. Studies were only considered if theyconcerned the description of a quality indicator set for (colo)rectal cancer. Papers wereexcluded if they were already included in the study of Patwardhan et al. The search waslimited to humans and to papers published in English, French, German or Dutch.The websites of the following organizations were also searched: the Agency forHealthcare Research and Quality (http://www.ahrq.gov/), the Joint Commission(http://www.jointcommission.org/), the Clinical Indicators Support Team(http://www.indicators.scot.nhs.uk/), and the National Health Service(http://www.nhs.uk/). The CPGs that were selected for the development of thePROCARE guideline were also evaluated for included QI [1]. Finally, the NationalQuality Measures Clearinghouse was also searched(http://www.qualitymeasures.ahrq.gov/).2.1.2 Definition of quality levelsThree quality levels were defined. The first level covers the QI that are affected by alltreatment phases and that were considered essential for general quality measurement.Second level QI were also considered essential for general quality measurement, but areaffected by one specific treatment phase (e.g. surgery). Finally, third level QI weredefined as those QI that deserved attention from individual centres if possible qualityproblems were identified through a level 1 or 2 QI. In other words, level 3 QI arerequired to interpret the results of level 1 and 2 QI.2.1.3 Selection process of quality indicatorsThe quality indicators identified through the literature search were summarized in anExcel-table per subdiscipline. For each quality indicator, an assessment was made by asmall working group, taking into account the following items:• relevance• level of evidence• related PROCARE recommendation(s)• quality levelOnly level 1 and 2 QI were considered for inclusion in the final quality indicator set. QIwere excluded if they did not specifically address rectal cancer care. Importantly,availability of data to allow measurement of the selected QI was not taken into accountduring the selection process.The final selection was discussed by a multidisciplinary team. In case important areaswere not covered by a QI from the literature, this multidisciplinary team proposedadditional QI based on key elements from the PROCARE guideline [1].
Page 1 and 2: Assurance de qualitépour le cancer
Page 3 and 4: Assurance de qualité pour lecancer
Page 5 and 6: KCE Reports 81B Cancer rectal - pha
Page 7: KCE Reports 81B Cancer rectal - pha
Page 10 and 11: vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13: 2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15: 4 PROCARE - phase 2 KCE reports 811
Page 19 and 20: KCE Reports 81 PROCARE - phase 2 92
Page 67 and 68:
KCE Reports 81 PROCARE - phase 2 57
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
KCE Reports 81 PROCARE - Phase 2 77
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169:
Page 172 and 173:
Dépôt légal : D/2008/10.273/39
Page 174 and 175:
35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?